Skip to main content
SpringerLink
Log in

News from ICER: November 2019

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Institute for Clinical and Economic Review. ICER Finalizes Method Adaptations for Assessing Potential Cures and Other High-Impact Single or Short-term Therapies. Internet Document : 12 Nov 2019. Available from: URL: https://icer-review.org/announcements/final_potential_cures_methods/

  2. Institute for Clinical and Economic Review. ICER Seeks Public Input to Guide Selection of Non-Drug Assessment Topics for 2020. Internet Document : 13 Nov 2019. Available from: URL: https://icer-review.org/announcements/potential_2020_non-drug_topics/

  3. Institute for Clinical and Economic Review. ICER Releases Evidence Report on JAK Inhibitors to Treat Rheumatoid Arthritis. Internet Document : 26 Nov 2019. Available from: URL: https://icer-review.org/announcements/jak_inhibitor_evidence_report/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

News from ICER: November 2019. PharmacoEcon Outcomes News 842, 2 (2019). https://doi.org/10.1007/s40274-019-6394-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6394-4

Search

Navigation